# DESCRIPTION

## FIELD OF THE INVENTION

- introduce invention overview

## BACKGROUND OF THE INVENTION

- describe testosterone function
- discuss testosterone deficiency
- summarize current testosterone therapies
- highlight limitations of current therapies
- motivate need for alternative methods

## SUMMARY OF THE INVENTION

- introduce testosterone administration objectives
- describe composition objectives
- outline method for increasing testosterone levels
- motivate need for alternative testosterone administration
- summarize side effects of testosterone therapy
- explain role of ornithine decarboxylase in testosterone effects
- describe inventors' discovery of ODC inhibition
- outline effects of follistatin on muscle and prostate
- summarize method for selective testosterone administration
- introduce low-testosterone associated disorder treatment
- describe method of treating low-testosterone disease
- detail composition of testosterone and ornithine decarboxylase inhibitor
- explain beneficial effects of testosterone administration
- describe side effects of testosterone administration
- introduce ornithine decarboxylase inhibitor
- detail effective amount of ornithine decarboxylase inhibitor
- describe pharmaceutical composition
- detail testosterone analogues
- describe ornithine decarboxylase inhibitors
- detail dosage of pharmaceutical composition
- describe side effects prevented by pharmaceutical composition
- introduce co-administrable combination of testosterone and ornithine decarboxylase inhibitor
- detail co-administrable combination
- describe methods for increasing testosterone levels
- detail methods for selectively promoting beneficial effects of testosterone
- describe methods for treating low testosterone levels
- detail methods for treating low-testosterone associated disorders
- introduce methods for treating hypogonadism in males
- describe diagnostic kit
- detail instructions for use of diagnostic kit

## DETAILED DESCRIPTION OF THE INVENTION

- introduce testosterone and ODC inhibitor combination
- describe selective effects on prostate and muscle growth
- outline pharmaceutical composition and co-administrable combination
- describe methods for increasing testosterone levels and treating disorders
- summarize kits and instructions for administration

### DEFINITIONS

- define antagonist
- define selective ODC inhibitor
- define decreased ODC activity
- define biologically active
- define isomer
- define combination therapy
- define low dose
- define treating
- define male sexual dysfunction
- define erectile dysfunction
- define pharmaceutically acceptable excipient
- define salts
- define pharmaceutically acceptable salt
- define subject
- define prodrug
- define therapeutically effective amount
- describe determination of therapeutically effective amount
- define pharmacologically effective amount
- define biologically active
- define pharmaceutically acceptable
- define administration
- define decrease, reduced, reduction, decrease, or inhibit
- define increased, increase, enhance, or activate
- define statistically significant
- define substantially
- define comprising, consisting essentially of, and consisting of
- define singular and plural forms
- provide general definitions and references

### Testosterone

- define testosterone
- describe chemical name and formula
- discuss isolation and purification methods
- introduce analogue of testosterone
- explain metabolite or precursor of testosterone
- discuss time point for administration of ODC inhibitor
- describe derivatives or salts of testosterone
- introduce fatty acid ester of testosterone
- discuss slow release of testosterone
- describe oral form of testosterone
- introduce undecanoate acid ester of testosterone
- discuss other esters of hydrophobic compounds
- describe pharmaceutical composition of testosterone
- discuss dose of testosterone alkyl ester
- introduce buccal gel form of testosterone
- describe transdermal patches of testosterone
- discuss administration of testosterone with ODC inhibitor
- describe peak plasma level of free testosterone
- discuss time lag in testosterone effect
- introduce composition comprising ODC inhibitor
- describe mean Cmax of testosterone
- discuss mean plasma Cmax of dihydrotestosterone
- describe ratio of testosterone equivalent dose to mean steady state testosterone Cmax
- discuss difference between mean plasma Cmax and Cmin of testosterone

### Compositions Comprising Testosterone or Analogues or Derivatives Thereof and ODC Inhibitors

- define composition
- introduce testosterone or analogue thereof
- introduce ornithine decarboxylase (ODC) inhibitor
- describe combination of testosterone and ODC inhibitor
- specify percentage of testosterone or analogue thereof
- define term "composition"
- describe separation of stereoisomers
- describe resolution of enantiomers
- describe formation of diastereomeric pairs
- describe resolution using chiral HPLC column
- list examples of testosterone analogues
- describe existence of stereoisomers
- describe solvates of compounds
- describe salts of compounds
- list examples of acid addition salts
- list examples of basic salts
- describe synthesis of salts
- describe use of salts in medicine
- describe prodrugs and solvates of compounds
- define compositions of testosterone analogues or derivatives and ODC inhibitors
- describe solvates and prodrugs of testosterone analogues or derivatives and ODC inhibitors
- discuss polymorphs of compounds
- describe stereoisomers of compounds
- introduce pharmaceutical compositions for treating low testosterone
- describe method for preventing and/or minimizing effects of low testosterone
- characterize effect of testosterone or analogues in combination with ODC inhibitors
- describe in vivo studies for assessing combination of testosterone and ODC inhibitor
- discuss formulation of combination for non-human animals
- introduce method for treating mammal with low testosterone levels
- describe co-administrable combination of testosterone and ODC inhibitor

### Method for Increasing Testosterone Levels in a Subject

- define method for increasing testosterone levels
- introduce testosterone and ODC inhibitor administration
- specify dosage of testosterone or analogue thereof
- describe side effects of testosterone administration
- introduce beneficial effects of testosterone
- specify embodiment for male subjects
- specify embodiment for female subjects
- introduce ornithine decarboxylase inhibitor options
- specify testosterone analogue options
- describe administration routes
- describe administration forms
- introduce method for treating hypogonadism
- describe diagnostic kit
- specify administration methods
- describe parenteral administration
- describe topical application
- introduce composition with pharmaceutically-acceptable carriers
- describe single dose administration
- describe multiple dose administration
- introduce simultaneous administration
- introduce sequential administration
- describe pulse-chase schedules
- introduce varying amounts of each agent
- describe daily dosages
- introduce pharmaceutical compositions

### Oral Formulations

- introduce oral formulations
- describe administration methods
- discuss advantages of oral administration
- describe problems with oral bioavailability
- propose solutions to bioavailability problems
- introduce trappsol and/or captisol for stability
- introduce cyclodextrin as alternative
- describe preservative challenge test
- introduce sweeteners for syrup formulation
- describe taste-masking effects of sweeteners
- introduce flavor options
- describe enteric coated formulation
- introduce tablet formulation with enteric polymer casing
- describe active ingredient in core
- introduce diluent, lubricant, and disintegrant
- describe weight ranges for core components
- introduce compacted mixture of components
- describe granulating process
- introduce enteric coating materials
- describe plasticiser and anti-tack agent
- introduce seal coat between core and enteric coating
- describe OPADRY coating
- introduce example of enteric-coated formulation
- describe manufacturing process for tablets
- introduce other enteric-coated preparations

### Doses and Administration Regimens

- define effective dosages
- describe bolus administration
- outline multiple dosing schedules
- discuss dosage level variation
- consider factors affecting dosage
- outline production regulations
- describe oversight of patient protocols
- discuss dosages and formulations
- outline methods for analyzing results
- describe safe compositions
- outline unwanted side effects
- discuss compositions for treating low testosterone
- describe combination therapies
- outline administration methods
- discuss dosing regimens
- describe administration routes
- outline additional therapies
- discuss prophylaxis treatment
- introduce doses and administration regimens
- motivate non-toxic compositions
- describe amount of composition in dosage form
- determine dosage from cell culture assays
- estimate therapeutically effective dose
- monitor effects of dosage
- adjust dosage by physician
- describe dosage ranges
- describe in vivo concentrations
- introduce regimens of administration
- describe therapeutic treatment
- describe prophylactic treatment
- discuss duration and frequency of treatment
- describe dosing schedules
- introduce pulsed administration
- describe pulsed administration for treatment
- describe pulsed administration for prophylaxis
- discuss intervals between pulses
- describe number of pulses in regimen
- discuss delivery methods
- describe cycles of treatment
- discuss co-administration with other agents
- describe combination with other active agents

### Low Testosterone Disorders and Subjects Amenable to Treatment

- introduce low testosterone disorders
- describe subjects amenable to treatment
- define hypogonadism
- specify male subjects with low testosterone levels
- specify female subjects with low testosterone levels
- describe subjects with exogenous testosterone therapy
- describe subjects with hypogonadism and serum total testosterone levels
- describe subjects with partial androgen deficiency
- describe subjects with sexual dysfunction
- describe subjects with benign prostatic hyperplasia
- describe methods for maintaining testosterone levels during aging
- describe correlations between low testosterone levels and diseases
- describe measurement of testosterone levels
- describe normal ranges for testosterone levels
- define bioavailable testosterone
- list symptoms of low testosterone
- describe andropause
- discuss age-dependent decline of testosterone levels
- identify subjects amenable to treatment
- specify testosterone levels for treatment
- describe subjects undergoing exogenous testosterone therapy
- identify hypogonadal subjects
- specify age ranges for treatment
- describe subjects with sexual dysfunction
- discuss correlations between low testosterone and diseases
- describe treatment of low-testosterone associated diseases
- identify additional subjects amenable to treatment

### Other Uses of the Methods and PDE8 Inhibitors Dual PDE8/PDE4 Inhibitor Compounds

- treat autoimmune diseases
- increase testosterone production
- treat anemia
- treat male menopause
- improve well-being
- enhance athletic performance
- treat sexual dysfunction

### Kits

- provide pharmaceutical packages
- include instructions for use
- optionally include other pharmaceutically active agents

## EXAMPLES

- illustrate invention with example 1

### Example 1

- introduce problem with testosterone
- describe inventors' discovery of follistatin
- demonstrate selective effect of follistatin on muscle
- propose anabolic drug combination

